TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms.
Borbulevych, Oleg Y
TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms. [electronic resource] - Journal of immunology (Baltimore, Md. : 1950) Sep 2011 - 2453-63 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1550-6606
10.4049/jimmunol.1101268 doi
Animals
Cross Reactions
Crystallography, X-Ray
Genetic Therapy--methods
HLA-A2 Antigen--chemistry
Humans
Immunotherapy--methods
MART-1 Antigen--chemistry
Neoplasms--immunology
Protein Binding
Protein Structure, Quaternary
Protein Structure, Secondary
Receptors, Antigen, T-Cell--chemistry
T-Lymphocytes--chemistry
TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms. [electronic resource] - Journal of immunology (Baltimore, Md. : 1950) Sep 2011 - 2453-63 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1550-6606
10.4049/jimmunol.1101268 doi
Animals
Cross Reactions
Crystallography, X-Ray
Genetic Therapy--methods
HLA-A2 Antigen--chemistry
Humans
Immunotherapy--methods
MART-1 Antigen--chemistry
Neoplasms--immunology
Protein Binding
Protein Structure, Quaternary
Protein Structure, Secondary
Receptors, Antigen, T-Cell--chemistry
T-Lymphocytes--chemistry